Gastroesophageal adenocarcinoma (GEA), which includes stomach, gastroesophageal junction, and esophageal cancers, remains one of the most challenging cancers to treat.
When Sam was diagnosed with a complex presentation of T-cell lymphoblastic lymphoma (T-LBL), his family and care team faced extraordinary challenges. As a young boy living with Down syndrome, his care required special medical support, family devotion and a strong community around them. Sam's story is featured as part of the Medical Stories docuseries, independently produced with Jazz Pharmaceuticals as a series sponsor.
Nick shares his experience recognizing early signs of stomach cancer, navigating diagnosis, learning the importance of HER2 testing, and finding strength through treatment, family support, and hope for the future.
The pace of progress in oncology continues to accelerate, driven by a deeper understanding of tumor biology and increasingly precise therapeutic approaches. That momentum is particularly meaningful in rare cancers, where unmet need remains high and rigorous science has the potential to make a real difference for patients.